-
Location
-
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, NY
-
Summary
-
The estimated net worth of Michael Aaron Kelly is at least $1.66M dollars as of June 6, 2025. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $450K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $410K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
-
Signature
-
/s/ Christian Formica, Attorney-in-Fact